BR112018016341A2 - solução de bloqueio do cateter e terapia de bloqueio do cateter - Google Patents

solução de bloqueio do cateter e terapia de bloqueio do cateter

Info

Publication number
BR112018016341A2
BR112018016341A2 BR112018016341-4A BR112018016341A BR112018016341A2 BR 112018016341 A2 BR112018016341 A2 BR 112018016341A2 BR 112018016341 A BR112018016341 A BR 112018016341A BR 112018016341 A2 BR112018016341 A2 BR 112018016341A2
Authority
BR
Brazil
Prior art keywords
catheter block
catheter
ethyl alcohol
solution
volume
Prior art date
Application number
BR112018016341-4A
Other languages
English (en)
Other versions
BR112018016341B1 (pt
Inventor
Babu Premkumar
R. BROZANSKI Benjamin
PAGANO Lisa
S. BENNETT Jeffrey
Original Assignee
Medical Components, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Components, Inc. filed Critical Medical Components, Inc.
Publication of BR112018016341A2 publication Critical patent/BR112018016341A2/pt
Publication of BR112018016341B1 publication Critical patent/BR112018016341B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M2025/0019—Cleaning catheters or the like, e.g. for reuse of the device, for avoiding replacement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

várias modalidades se referem a soluções de bloqueio de cateter e terapias de bloqueio de cateter com uso de citrato trissódico e álcool etílico e, em particular, 4,0 a 15,0% em peso/volume de citrato trissódico como componente anticoagulante e/ou componente antibacteriano e 15,0 a 25,0 % volume/volume de álcool etílico como um componente antibacteriano. a utilização da solução de bloqueio de cateter e a terapia de bloqueio de cateter pode reduzir a falha do tratamento durante procedimentos médicos que podem empregar cateteres para fornecer tratamento pelo menos reduzindo significativamente os riscos associados a infecções da corrente sanguínea, mau funcionamento do sistema de cateter, formação de êmbolos, desconforto do paciente e doença do paciente. estes benefícios podem ser parcialmente devidos aos efeitos antibacterianos sinérgicos do citrato trissódico e do álcool etílico em solução, gerando uma solução eficaz de bloqueio do cateter com concentrações mínimas de álcool etílico.
BR112018016341-4A 2016-02-12 2017-02-06 Solução de bloqueio de cateter BR112018016341B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662294478P 2016-02-12 2016-02-12
US62/294,478 2016-02-12
PCT/US2017/016682 WO2017139224A1 (en) 2016-02-12 2017-02-06 Catheter locking solution and catheter locking therapy

Publications (2)

Publication Number Publication Date
BR112018016341A2 true BR112018016341A2 (pt) 2018-12-18
BR112018016341B1 BR112018016341B1 (pt) 2022-02-08

Family

ID=58191579

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018016341-4A BR112018016341B1 (pt) 2016-02-12 2017-02-06 Solução de bloqueio de cateter

Country Status (13)

Country Link
US (2) US10940240B2 (pt)
EP (1) EP3413942B1 (pt)
JP (1) JP6909226B2 (pt)
CN (1) CN108697826A (pt)
AU (2) AU2017217011B2 (pt)
BR (1) BR112018016341B1 (pt)
CA (1) CA3013914C (pt)
ES (1) ES2936820T3 (pt)
IL (1) IL260771B2 (pt)
MX (2) MX2018009764A (pt)
RU (1) RU2734929C2 (pt)
TW (1) TWI738714B (pt)
WO (1) WO2017139224A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US12064567B2 (en) 2015-07-20 2024-08-20 Roivios Limited Percutaneous urinary catheter
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US10493232B2 (en) 2015-07-20 2019-12-03 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
US11541205B2 (en) * 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US10512713B2 (en) 2015-07-20 2019-12-24 Strataca Systems Limited Method of removing excess fluid from a patient with hemodilution
CA3152431A1 (en) 2015-07-20 2017-01-26 Roivios Limited Ureteral and bladder catheters and methods for inducing negative pressure to increase renal perfusion
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
CA3047165A1 (en) 2016-12-27 2018-07-05 Vasonics, Llc Catheter housing
CN115120791A (zh) 2017-08-25 2022-09-30 罗维奥斯有限公司 促进从尿道除尿的排尿泵
WO2019060697A1 (en) * 2017-09-22 2019-03-28 Becton, Dickinson And Company 4% TRISODIC CITRATE SOLUTION FOR USE AS A CATHETER LOCK SOLUTION
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1097336A1 (ru) 1982-04-21 1984-06-15 Институт сердечно-сосудистой хирургии им.А.Н.Бакулева Способ получени тромборезистентных полимерных изделий,контактирующих с кровью
AU5689199A (en) * 1998-08-25 2000-03-14 Ash Medical Systems, Inc. Method of enhancing catheter patency using a citrate salt catheter lock solution
US6679870B1 (en) * 1999-07-23 2004-01-20 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6685694B2 (en) 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
EP1284780B1 (en) 2000-05-10 2008-05-07 Ash Access Technology, Inc. A catheter lock solution including a photo-oxidant
JP5143982B2 (ja) * 2001-05-08 2013-02-13 エヌディー パートナーズ，リミティド ライアビリティー カンパニー 殺生物剤ロック
US20050215978A1 (en) * 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
US8541472B2 (en) * 2001-12-05 2013-09-24 Aseptica, Inc. Antiseptic compositions, methods and systems
US20030144362A1 (en) 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US20050136118A1 (en) 2003-12-19 2005-06-23 Wu Su-Syin S. Distribution and preparation of germicidal compositions
US7749529B2 (en) * 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
EP1998825B1 (en) * 2006-02-28 2017-10-18 Becton, Dickinson and Company Antimicrobial compositions and methods for locking catheters
US20080279907A1 (en) * 2007-05-10 2008-11-13 Ash Access Technology, Inc. Antimicrobial medical devices and methods for making and using same
CN101112627B (zh) * 2007-05-29 2011-12-21 中国人民解放军第二军医大学 封管用枸橼酸钠注射液及其制备方法
DE102007036685A1 (de) 2007-08-03 2009-02-05 Innora Gmbh Verbesserte arzneimittelbeschichtete Medizinprodukte deren Herstellung und Verwendung
US9248093B2 (en) * 2009-06-11 2016-02-02 Becton, Dickinson And Company Catheter locking solution having antimicrobial and anticoagulation properties
CA2793832C (en) 2010-03-25 2018-09-18 Lixiao Wang Drug releasing coatings for medical devices
US8951577B2 (en) 2010-08-03 2015-02-10 Teleflex Medical Incorporated Antimicrobial hydrochloric acid catheter lock solution and method of use
WO2012034032A2 (en) 2010-09-10 2012-03-15 The Board Of Regents Of Unbiversity Of Texas System Antimicrobial solutions
FR2985667B1 (fr) 2012-01-12 2014-08-22 Univ Dauvergne Clermont I Composition verrou aqueuse comprenant de l'ethanol et un anticoagulant polysaccharidique
JP6175140B2 (ja) * 2012-08-08 2017-08-02 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 硝酸グリセリン類を含む抗菌組成物
WO2015077798A1 (en) 2013-11-25 2015-05-28 Excelsior Medical Corporation Catheter lock solution formulations

Also Published As

Publication number Publication date
TW201731553A (zh) 2017-09-16
RU2018132353A3 (pt) 2020-05-20
RU2734929C2 (ru) 2020-10-26
AU2017217011B2 (en) 2021-06-03
CA3013914C (en) 2024-02-06
EP3413942A1 (en) 2018-12-19
US20170232153A1 (en) 2017-08-17
JP6909226B2 (ja) 2021-07-28
AU2021203473A1 (en) 2021-06-24
MX2022004012A (es) 2022-05-02
IL260771B2 (en) 2023-09-01
US20210170075A1 (en) 2021-06-10
AU2017217011A1 (en) 2018-08-09
WO2017139224A1 (en) 2017-08-17
IL260771A (pt) 2018-09-20
TWI738714B (zh) 2021-09-11
RU2018132353A (ru) 2020-03-12
CN108697826A (zh) 2018-10-23
RU2020134168A (ru) 2020-11-24
CA3013914A1 (en) 2017-08-17
JP2019506223A (ja) 2019-03-07
ES2936820T3 (es) 2023-03-22
MX2018009764A (es) 2018-09-10
US10940240B2 (en) 2021-03-09
RU2020134168A3 (pt) 2021-09-14
EP3413942B1 (en) 2023-01-11
IL260771B1 (en) 2023-05-01
BR112018016341B1 (pt) 2022-02-08

Similar Documents

Publication Publication Date Title
BR112018016341A2 (pt) solução de bloqueio do cateter e terapia de bloqueio do cateter
BR112018075682A2 (pt) inibidores de papd5 e papd7 para tratamento de infecção pela hepatite b
BR112018016001A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
BR112017024934A2 (pt) composições farmacêuticas tópicas
BR112016000177A2 (pt) usos de um antagonista do vegf no tratamento de doenças neovasculares coriorretinianas e de permeabilidade em pacientes pediátricos, seringa pré-cheia, kit e formulação de liberação lenta
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112016013961A2 (pt) angiotensina ii sozinha ou em combinação para o tratamento da hipotensão
BR112013018920A2 (pt) composições de nanopartículas, formulações destas e seus usos
CL2018000002A1 (es) Agente terapéutico y método para tratar el síndrome de hunter.
BR112015021334A2 (pt) formulações oculares para entrega de droga ao segmento posterior do olho
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
BR112017006272A2 (pt) composição farmacêutica para tratar colite ulcerativa.
BR112015022650A2 (pt) inibidores de cinase induzível por sal macrocíclico
BR112017000058A2 (pt) dispositivos e métodos para esclero espumas vasculares injetáveis utilizando uma matriz carreadora e seus usos
BR112016025481A2 (pt) alimentos, sistemas, métodos e estojos para provisão de substituição de eletrólito
HRP20200031T1 (hr) Uporaba cerebrolizina
BR112015023806A2 (pt) Novos regimes de dosagem de celgosivir para o tratamento de dengue
BR112019018185A2 (pt) composição para tratar uma doença de articulação humana, e, kit.
BR112018072177A2 (pt) composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta
BR112015009291A2 (pt) métodos para o controle da pressão arterial e redução da dispnéia na insuficiência cardíaca
BR112014003270A2 (pt) métodos e aparelhos para o cvcs
MD3619G2 (ro) Remediu medicamentos nazal cu acţiune anticongestivă
BR112018072183A2 (pt) composição farmacêutica, e, método para prevenir uma doença de pele
Burki et al. A novel extracorporeal CO2 removal system: application of the hemolung in patients with hypercapnic respiratory failure
BR112015021363A2 (pt) adrenérgico alfa-2 para tratamento pressão intraocular e doenças oculares através de vias intravítreas e intracamerais

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/02/2017, OBSERVADAS AS CONDICOES LEGAIS.